doi: 10.1111/dom.16378
While GLP-1 medications have FDA-approved dosing schedules, microdosing itself has not been specifically studied or approved by the FDA
In healthy fasted individuals, it is recognized that peripheral plasmatic active GLP-1 (7-36) NH2 plasmatic levels hover around 5 pM, but within 510 min after an oral glucose load, they start to rise, up to a maximum of less than 10 pM after 4090 min, and slowly descend back to baseline values in 150 min
BPC-157, TB-500, semaglutide, tirzepatide, and GHK-Cu use the same starting doses regardless of sex
They are not regulated and tested like prescription medications, meaning they may not be effective, could have unknown side effects, or contain hidden (and potentially dangerous) ingredients
Clinical Outcomes: Post-Weight Loss Restoration The Piazza Center Guide to Scalp and Body Maintenance During Weight Loss Restoration FAQ Why am I losing hair and muscle on my weight loss medication